Effect of Patient State Index Monitoring on the Recovery Characteristics in Morbidly Obese Patients: Comparison of Inhalation Anesthesia and Total Intravenous Anesthesia

J Perianesth Nurs. 2021 Feb;36(1):69-74. doi: 10.1016/j.jopan.2020.07.005. Epub 2020 Oct 1.

Abstract

Purpose: Obese patients have a significantly higher risk of adverse effects associated with general anesthesia. The purpose of this study was to evaluate the effects of Patient State Index (PSI) monitoring on recovery from anesthesia and the incidence of any postoperative complications among patients undergoing bariatric surgery with total intravenous anesthesia (TIVA) and inhalational anesthesia.

Design: This prospective, double-blind, and randomized controlled trial was conducted between February 2017 and August 2017 and included 120 morbidly obese patients (body mass index >40 kg/m2).

Methods: Patients were randomly divided into four groups; group P-PSI (n = 30): TIVA with PSI monitoring; group P (n = 30): TIVA without PSI monitoring; group D-PSI (n = 30): desflurane with PSI monitoring; and group D (n = 30): desflurane without PSI monitoring. The discharge time from the postanesthesia care unit (PACU), postoperative complications, and hemodynamic parameters were recorded and evaluated.

Findings: No significant differences were found in demographic data, duration of anesthesia, admittance to PACU, discharge from PACU, modified Aldrete scores, and perioperative mean blood pressure and heart rate. Nausea and vomiting scores were significantly lower in group P-PSI, group P, and group D-PSI compared with group D.

Conclusions: Although TIVA and inhalational anesthesia can be safely used for obese patients, intraoperative PSI monitoring may decrease the discharge time from PACU and reduces incidence of postoperative nausea and vomiting caused by inhalation anesthetics.

Keywords: PACU; PSI monitoring; TIVA; inhalation anesthesia; morbid obesity.

Publication types

  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Anesthesia Recovery Period*
  • Anesthesia, Inhalation / adverse effects
  • Anesthesia, Intravenous / adverse effects
  • Bariatric Surgery
  • Double-Blind Method
  • Humans
  • Monitoring, Intraoperative*
  • Obesity, Morbid* / surgery
  • Postoperative Complications* / epidemiology
  • Prospective Studies